Liquid Biopsy: minimal-invasive analysis of somatic alterations-Reference-Cited by-同舟云学术

Liquid Biopsy: minimal-invasive analysis of somatic alterations

Published:2023-11-29 Issue:4 Volume:35 Page:199-200
ISSN:1863-5490
Container-title:Medizinische Genetik
language:en
Short-container-title:

Author:

Hallermayr Ariane¹^ORCID

Affiliation:

1. MGZ – Medizinisch Genetisches Zentrum München Germany

Publisher

Walter de Gruyter GmbH

Subject

Genetics (clinical),Genetics

Link

https://www.degruyter.com/document/doi/10.1515/medgen-2023-2061/pdf

Reference19 articles.

1. Alberry MS, Aziz E, Ahmed SR, Abdel-fattah S (2021) Non invasive prenatal testing (NIPT) for common aneuploidies and beyond. European Journal of Obstetrics & Gynecology and Reproductive Biology 258:424–429. https://doi.org/10.1016/j.ejogrb.2021.01.008

2. Ashworth T (1869) A Case of Cancer in Which Cells Similar to Those in the Tumors Were Seen inthe Blood after Death. Medical Journal of Australia 14:146–149

3. Bidard F-C, Hardy-Bessard A-C, Dalenc F et al (2022) Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol 23:1367–1377. https://doi.org/10.1016/S1470-2045(22)00555-1

4. Bohaumilitzky L, Gebert J, von Knebel Doeberitz M et al (2023) Liquid biopsy-based early tumor and minimal residual disease detection: New perspectives for cancer predisposition syndromes. Medizinische Genetik

5. Bronkhorst AJ, Holdenrieder S (2023) The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization. Medizinische Genetik